Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetic profile of ropivacaine after periarticular local infiltration analgesia in primary total knee arthroplasty
NL-OMON40725Phase 4Active, not recruiting
- Sponsor
- Sint Maartenskliniek
- Start
- Jan 2015
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of ropivacaine in postoperative pain, sponsored by Sint Maartenskliniek. Primary endpoints: Mean total maximum serum concentration of ropivacaine, Mean unbound maximum serum concentration of ropivacaine and 2 more. Started Jan 2015; status: active, not recruiting.
02
Drugs
ropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NL-OMON40725.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON40725.